Evidence map›Paper›PMID 36712058›Full record

ArticlebioRxiv : the preprint server for biology2023

Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early pre-neoplastic pancreatic lesions.

Eileen S Carpenter, Ahmed M Elhossiny, Padma Kadiyala, Jay Li, Jake McGue, Brian Griffith, Yaqing Zhang, Jacob Edwards, Sarah Nelson, Fatima Lima and 19 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 2 institutions in 1 country.

Eileen S CarpenterDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.
Ahmed M ElhossinyDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI.
Padma KadiyalaImmunology Graduate Program, University of Michigan, Ann Arbor, MI.
Jay LiMedical Scientist Training Program, University of Michigan, Ann Arbor, MI.
Jake McGueDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Brian GriffithDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Yaqing ZhangDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Jacob EdwardsDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Sarah NelsonDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Fatima LimaDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Katelyn L DonahueCancer Biology Program, University of Michigan, Ann Arbor, MI.
Wenting DuDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Allison C BischoffCancer Biology Program, University of Michigan, Ann Arbor, MI.
Danyah AlomariDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.
Hannah WatkoskeDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Michael MatteaDepartment of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI.
Stephanie TheCancer Data Science Resource, University of Michigan, Ann Arbor, MI.
Carlos EspinozaDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Meredith BarrettDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Christopher J SonnendayDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Nicholas OldenGift of Life Michigan, MI.
Nicole PetersonDepartment of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI.
Valerie GunchickDepartment of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI.
Vaibhav SahaiRogel Cancer Center, University of Michigan, Ann Arbor, MI.
Arvind RaoRogel Cancer Center, University of Michigan, Ann Arbor, MI.
Filip BednarDepartment of Surgery, University of Michigan, Ann Arbor, MI.
Jiaqi ShiRogel Cancer Center, University of Michigan, Ann Arbor, MI.
Timothy L FrankelRogel Cancer Center, University of Michigan, Ann Arbor, MI.
Marina Pasca Di MaglianoRogel Cancer Center, University of Michigan, Ann Arbor, MI.
University of Michigan · USGift of Life Michigan · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic CancerU54CA274371 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ANIRBAN MAITRA · 2022 to 2026
$9.5M
Fibroblast orchestration of the immune response in pancreatic cancerU01CA274154 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Howard C. Crawford, Timothy Louis Frankel · 2022 to 2026
$4.2M
Synthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade GliomasR37CA214955 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KURTEK, SEBASTIAN, RAO, ARVIND · 2018 to 2024
$3.9M
Training in Basic and Translational Digestive SciencesT32DK094775 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JOHN Y KAO, LINDA C. SAMUELSON · 2012 to 2026
$3.6M
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironmentR01CA260752 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PASCA DI MAGLIANO, MARINA · 2022 to 2025
$2.8M
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.R01CA271510 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Filip Bednar, Marina Pasca Di Magliano · 2022 to 2026
$2.6M
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas CancerU01CA224145 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CRAWFORD, HOWARD C., PASCA DI MAGLIANO, MARINA · 2017 to 2021
$2.6M
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesisR01CA268426 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Timothy Louis Frankel, Marina Pasca Di Magliano · 2023 to 2026
$2.5M
Defining epigenetic signaling to reshape pancreatic tumor microenvironmentR37CA262209 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jiaqi Shi · 2022 to 2026
$2.3M
BLRD VA I01 BX005777BLRD VA IK2 BX005875NCI NIH HHS F31 CA265085NCI NIH HHS K08 CA234222NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA260752NCI NIH HHS R01 CA264843NCI NIH HHS R01 CA268426NCI NIH HHS R01 CA271510NCI NIH HHS R37 CA214955NCI NIH HHS R37 CA262209NCI NIH HHS U01 CA224145NCI NIH HHS U01 CA274154NCI NIH HHS U54 CA274371NIAID NIH HHS T32 AI007413NIDDK NIH HHS R01 DK128102NIDDK NIH HHS T32 DK094775NIGMS NIH HHS T32 GM007863NIGMS NIH HHS T32 GM113900
6 · The paper itself

Abstract

The adult healthy human pancreas has been poorly studied given lack of indication to obtain tissue from the pancreas in the absence of disease and rapid postmortem degradation. We obtained pancreata from brain dead donors thus avoiding any warm ischemia time. The 30 donors were diverse in age and race and had no known pancreas disease. Histopathological analysis of the samples revealed PanIN lesions in most individuals irrespective of age. Using a combination of multiplex immunohistochemistry, single cell RNA sequencing, and spatial transcriptomics, we provide the first ever characterization of the unique microenvironment of the adult human pancreas and of sporadic PanIN lesions. We compared healthy pancreata to pancreatic cancer and peritumoral tissue and observed distinct transcriptomic signatures in fibroblasts, and, to a lesser extent, macrophages. PanIN epithelial cells from healthy pancreata were remarkably transcriptionally similar to cancer cells, suggesting that neoplastic pathways are initiated early in tumorigenesis. Statement of significance: The causes underlying the onset of pancreatic cancer remain largely unknown, hampering early detection and prevention strategies. Here, we show that PanIN are abundant in healthy individuals and present at a much higher rate than the incidence of pancreatic cancer, setting the stage for efforts to elucidate the microenvironmental and cell intrinsic factors that restrain, or, conversely, promote, malignant progression.

Identifiers

PMID36712058
PMCPMC9882230
OpenAlexW4316344922

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.